{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:18:22Z","timestamp":1793215102472,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":168,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.semnephrol.2025.151569","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T20:33:57Z","timestamp":1741811637000},"page":"151569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["IgAN Across the Age Spectrum: The Pediatric Perspective"],"prefix":"10.1016","volume":"44","author":[{"given":"Licia","family":"Peruzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2025.151569_bib0001","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151569_bib0002","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40620-016-0360-z","article-title":"Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients","volume":"30","author":"Coppo","year":"2017","journal-title":"J Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151569_bib0003","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40620-020-00725-0","article-title":"IgA nephropathy in children and in adults: two separate entities or the same disease?","volume":"33","author":"Coppo","year":"2020","journal-title":"J Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151569_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2019.0600","article-title":"Evaluating a new International Risk-Prediction Tool in IgA nephropathy","volume":"179","author":"Barbour","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151569_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151569_bib0006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2215\/CJN.07420716","article-title":"IgA nephropathy","volume":"12","author":"Rodrigues","year":"2017","journal-title":"CJASN"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151569_bib0007","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ndt\/gfy302","article-title":"Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford classification for IgA nephropathy (VALIGA) update","volume":"35","author":"Coppo","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0008","first-page":"109","article-title":"Survival on renal replacement therapy: data from the EDTA registry","volume":"3","author":"Brunner","year":"1988","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151569_bib0009","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","article-title":"Epidemiology of IgA nephropathy: a global perspective","volume":"38","author":"Schena","year":"2018","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10157-015-1129-8","article-title":"Epidemiological survey and clinical investigation of pediatric IgA nephropathy","volume":"20","author":"Shibano","year":"2016","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151569_bib0011","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000495751","article-title":"Pediatric IgA nephropathy in Europe","volume":"5","author":"Coppo","year":"2019","journal-title":"Kidney Dis"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151569_bib0012","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/ndt\/gfad082","article-title":"The incidence and prevalence of IgA nephropathy in Europe","volume":"38","author":"Willey","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151569_bib0013","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ndt\/gfx189","article-title":"Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey","volume":"33","author":"O'Shaughnessy","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151569_bib0014","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s10157-021-02077-w","article-title":"Clinical and histological features in pediatric and adolescent\/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR)","volume":"25","author":"Urushihara","year":"2021","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10157-012-0746-8","article-title":"Japan Renal Biopsy Registry and Japan Kidney Disease Registry: committee report for 2009 and 2010","volume":"17","author":"Sugiyama","year":"2013","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0016","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10157-012-0672-9","article-title":"A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management","volume":"17","author":"Cho","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/5584_2016_65","article-title":"IgA nephropathy in children: a multicenter study in Poland","volume":"952","author":"Mizerska-Wasiak","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151569_bib0018","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/ckj\/sfz023","article-title":"Trends of renal diseases in Germany: review of a regional renal biopsy database from 1990 to 2013","volume":"12","author":"Zink","year":"2019","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151569_bib0019","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2215\/CJN.11461017","article-title":"The spectrum of biopsy-proven glomerular diseases among children in China: a national, cross-sectional survey","volume":"13","author":"Nie","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151569_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152203","article-title":"Epidemiology of histologically proven glomerulonephritis in Africa: a systematic review and meta-analysis","volume":"11","author":"Okpechi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0021","article-title":"Updating the International IgA Nephropathy Prediction Tool for use in children","author":"Barbour","year":"2020","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151569_bib0022","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00467-024-06361-1","article-title":"Are children with IgA nephropathy different from adult patients?","volume":"39","author":"Su","year":"2024","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151569_bib0023","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2014.63","article-title":"Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments","volume":"86","author":"Coppo","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151569_bib0024","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ekir.2018.03.013","article-title":"Immunosuppressive treatment in children with IgA nephropathy and the clinical value of podocytopathic features","volume":"3","author":"Cambier","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151569_bib0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00467-016-3502-6","article-title":"IgA nephropathy with presentation of nephrotic syndrome at onset in children","volume":"32","author":"Shima","year":"2017","journal-title":"Pediatric Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151569_bib0026","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00467-021-05092-x","article-title":"An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy","volume":"37","author":"Hogg","year":"2022","journal-title":"Pediatric Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151569_bib0027","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000168080","article-title":"IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features","volume":"10","author":"Okada","year":"1990","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151569_bib0028","first-page":"610","article-title":"Clinical and pathological analysis of IgA nephropathy with acute kidney injury","volume":"54","author":"Chen","year":"2016","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0029","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2215\/CJN.01970211","article-title":"AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences","volume":"7","author":"Moreno","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0030","doi-asserted-by":"crossref","first-page":"sfad252","DOI":"10.1093\/ckj\/sfad252","article-title":"Oral anticoagulant treatment and risk of kidney disease-a nationwide, population-based cohort study","volume":"17","author":"Vestergaard","year":"2024","journal-title":"Clin Kidney J"},{"issue":"1-2","key":"10.1016\/j.semnephrol.2025.151569_bib0031","doi-asserted-by":"crossref","DOI":"10.1159\/000342385","article-title":"Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of igA nephropathy","volume":"121","author":"Guti\u00e9rrez","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0032","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000498874","article-title":"Crescents and global glomerulosclerosis in Chinese IgA nephropathy patients: a five-year follow-up","volume":"44","author":"Peng","year":"2019","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0033","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00467-014-2954-9","article-title":"The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy","volume":"30","author":"Coppo","year":"2014","journal-title":"Pediatric Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151569_bib0034","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/ckj\/sfad134","article-title":"The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort","volume":"16","author":"Guo","year":"2023","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151569_bib0035","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ndt\/gfg081","article-title":"Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide","volume":"18","author":"Tumlin","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0036","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-012-2294-6","article-title":"Spontaneous remission in children with IgA nephropathy","volume":"28","author":"Shima","year":"2013","journal-title":"Pediatric Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151569_bib0037","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00467-015-3176-5","article-title":"Long-term outcome of childhood IgA nephropathy with minimal proteinuria","volume":"30","author":"Higa","year":"2015","journal-title":"Pediatric Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0038","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00467-023-06116-4","article-title":"Factors related to recurrence of proteinuria in childhood IgA nephropathy","volume":"39","author":"Shima","year":"2024","journal-title":"Pediatric Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151569_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9072058","article-title":"Remission of proteinuria may protect against progression to chronic kidney disease in pediatric-onset IgA nephropathy","volume":"9","author":"Suh","year":"2020","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151569_bib0040","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1007\/s00467-023-05968-0","article-title":"A pediatric case of IgA nephropathy benefitting from targeted release formulation\u2013budesonide","volume":"38","author":"Antonucci","year":"2023","journal-title":"Pediatric Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0041","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40620-016-0360-z","article-title":"Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients","volume":"30","author":"Coppo","year":"2017","journal-title":"J Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0042","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1681\/ASN.V82199","article-title":"Predicting renal outcome in IgA nephropathy","volume":"8","author":"Radford","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151569_bib0043","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","article-title":"Remission of proteinuria improves prognosis in IgA nephropathy","volume":"18","author":"Reich","year":"2007","journal-title":"JASN"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0044","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00467-016-3469-3","article-title":"Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort","volume":"32","author":"Coppo","year":"2017","journal-title":"Pediatric Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2025.151569_bib0045","doi-asserted-by":"crossref","first-page":"ii19","DOI":"10.1093\/ckj\/sfad232","article-title":"Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients","volume":"16","author":"Zand","year":"2023","journal-title":"Clin Kidney J"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151569_bib0046","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1681\/ASN.2017010108","article-title":"Remission of hematuria improves renal survival in IgA nephropathy","volume":"28","author":"Sevillano","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151569_bib0047","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2017060639","article-title":"Persistent microscopic hematuria as a risk factor for progression of IgA nephropathy: new floodlight on a nearly forgotten biomarker","volume":"28","author":"Coppo","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151569_bib0048","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/ndt\/gfn014","article-title":"IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes","volume":"23","author":"Haas","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151569_bib0049","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ki.2010.43","article-title":"The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults","volume":"77","author":"Coppo","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/ndt\/gfr339","article-title":"Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification)","volume":"27","author":"Edstr\u00f6m Halling","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151569_bib0051","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-011-2061-0","article-title":"Validity of the Oxford classification of IgA nephropathy in children","volume":"27","author":"Shima","year":"2012","journal-title":"Pediatric Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151569_bib0052","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jped.2016.09.003","article-title":"Preditores da doen\u00e7a renal cr\u00f4nica segundo a Classifica\u00e7\u00e3o de Oxford em pacientes pedi\u00e1tricos com nefropatia por IgA","volume":"93","author":"Fabiano","year":"2017","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0053","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2313174","article-title":"External validation of the international prognosis prediction model of IgA nephropathy","volume":"46","author":"Hu","year":"2024","journal-title":"Ren Fail"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0054","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2147\/CIA.S455115","article-title":"External validation of the International IgA Nephropathy Prediction Tool in older adult patients","volume":"19","author":"Zhang","year":"2024","journal-title":"Clin Interv Aging"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151569_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00467-016-3502-6","article-title":"IgA nephropathy with presentation of nephrotic syndrome at onset in children","volume":"32","author":"Shima","year":"2017","journal-title":"Pediatric Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0056","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-13-158","article-title":"Validation of the Oxford classification of IgA nephropathy for pediatric patients from China","volume":"13","author":"Le","year":"2012","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151569_bib0057","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0058","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1183562","article-title":"Validation of the children international IgA nephropathy prediction tool based on data in Southwest China","volume":"11","author":"Yu","year":"2023","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0059","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.kint.2022.02.042","article-title":"Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy","volume":"102","author":"Barbour","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2024.07.012","article-title":"Application of the updated International IgA Nephropathy Prediction Tool in children one- or two-years post-biopsy","author":"Barbour","year":"2024","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151569_bib0061","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00467-018-4189-7","article-title":"Steroid therapy in children with IgA nephropathy","volume":"35","author":"Cambier","year":"2020","journal-title":"Pediatric Nephrol"},{"issue":"9156","key":"10.1016\/j.semnephrol.2025.151569_bib0062","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: a randomised controlled trial","volume":"353","author":"Pozzi","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0063","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","article-title":"Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial","volume":"15","author":"Pozzi","year":"2004","journal-title":"JASN"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151569_bib0064","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1093\/ndt\/gfp356","article-title":"Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy","volume":"24","author":"Manno","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"23","key":"10.1016\/j.semnephrol.2025.151569_bib0065","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","article-title":"Intensive supportive care plus immunosuppression in IgA nephropathy","volume":"373","author":"Rauen","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151569_bib0066","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.kint.2023.11.003","article-title":"Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial","volume":"105","author":"Wimbury","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151569_bib0067","article-title":"Targeting APRIL in the treatment of IgA nephropathy","author":"Cheung","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0068","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2305635","article-title":"A phase 2 trial of Sibeprenlimab in patients with IgA nephropathy","volume":"390","author":"Mathur","year":"2024","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.semnephrol.2025.151569_bib0069","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s40265-023-01940-2","article-title":"Current understanding of complement proteins as therapeutic targets for the treatment of immunoglobulin A nephropathy","volume":"83","author":"Rajasekaran","year":"2023","journal-title":"Drugs"},{"issue":"March","key":"10.1016\/j.semnephrol.2025.151569_bib0070","first-page":"1","article-title":"The emerging role of complement proteins as a target for therapy of IgA nephropathy","volume":"10","author":"Rizk","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151569_bib0071","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.kint.2023.10.012","article-title":"A new alternative: inhibiting complement activation in patients with IgA nephropathy","volume":"105","author":"Floege","year":"2024","journal-title":"Kidney Int"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T14:50:28Z","timestamp":1746543028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929525000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0270929525000063"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151569","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgAN Across the Age Spectrum: The Pediatric Perspective","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151569"}}